Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by investclubon Dec 03, 2019 4:58pm

114 Views

Post# 30418818

RE:RE:RE:How much study drug do we need?

enriquesuave wrote

Was thinking the same thing Vestor. Got to get ready for the Big battle Big Pharma will play out here Who knows?

vestor111 wrote: Nice Eogan! Interesting...dual sourcing. Maybe to put some distance between Merck and TLT at the request of some would-be suitor? Hmmm.

That would be my main thought as well enriquesuave & vestor111 but one thing I did learn from small and large businesses never have a main source of your product or service reliance on 1 individual or 1 company by splitting that source into two or more lessens a production problem which could cripple or cause a shutdown to your business or an opportunity for one source to increase cost to you for that product.

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages